糖尿病分娩妇女的母乳养模式:MOMPOD随机临床试验的二次分析
Minhazur Sarker1, Marni B Jacobs1, Kim Boggess2
1University of California San Diego, San Diego, CA USA.
Pregnancy (Hoboken, N.J.)
|May 16, 2025
概括
在怀孕期间使用甲福明并没有改善2型糖尿病或早期糖尿病患者的母乳养率. 这项研究发现,甲福明与开始或继续母乳养之间没有关联.
科学领域:
- 生殖内分泌学 生殖内分泌学
- 孕产妇和胎儿医学 孕产妇和胎儿医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 胰岛素抵抗与哺乳期个体的乳供应减少有关.
- 梅特福林通过降低胰岛素耐药性来改善母乳生产的潜力表明,它可能会提高母乳养的成功率.
研究的目的:
- 调查在怀孕期间使用甲福明和开始和继续母乳养之间的关联.
主要方法:
- 对MOMPOD随机对照试验 (甲福林与安慰剂) 的二次分析.
- 包括怀孕的2型或早期糖尿病患者打算母乳养的孕妇.
- 通过问卷评估了母乳养的开始,产后30天的继续,乳腺发育的开始和母乳养的挑战.
主要成果:
- 在甲福明和安慰剂组之间,基线特征没有显著差异.
- 立即母乳养率 (91.1%与88.9%) 和乳腺发育的发病率是可比的.
- 在产后30天的母乳养 (76.0%与66.7%) 或完全/部分母乳养,乳房大小或挑战没有差异.
结论:
- 怀孕期间使用甲福林与2型糖尿病或早期糖尿病患者的母乳养模式没有关联.
- 产前甲福明不应该仅仅是为了提高母乳养成功而推.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
4.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
Pathophysiology of Diabetes
3.9K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Development of Human Microbiota
61
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
61
Development of the Oral Microbiota
65
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
65


